Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph L Pater

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 20, 2002
Ethics and industry-sponsored researchJoseph L Pater, Wendy Parulekar, Christopher O'Callagham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 2, 2022
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials GroupLouis Everest, Scott Blommaert, Dongsheng Tu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2015
Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcomeJose G Monzon, Annette E Hay, Gail T McDonald, et al.
Clinical Trials (London, England)|November 24, 2018
Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomesAnnette E Hay, Joseph L Pater, Elyse Corn, et al.
Journal of the National Cancer Institute|March 24, 2021
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group ExperienceJoseph C Del Paggio, Adam M Fundytus, Wilma M Hopman, et al.
Journal of Pain and Symptom Management|April 3, 2007
A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patientsDeborah J Dudgeon, Eduardo Bruera, Bruno Gagnon, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 19, 2020
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the LiteratureBethany E Monteith, Christopher P Venner, Donna E Reece, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)Andrea Bezjak, Peter Dixon, Michael Brundage, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry DataAnnette E Hay, Nicole Mittmann, Michael Crump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2005
Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal womenTimothy J Whelan, Paul E Goss, James N Ingle, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 20, 2002
Ethics and industry-sponsored researchJoseph L Pater, Wendy Parulekar, Christopher O'Callagham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 2, 2022
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials GroupLouis Everest, Scott Blommaert, Dongsheng Tu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2015
Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcomeJose G Monzon, Annette E Hay, Gail T McDonald, et al.
Clinical Trials (London, England)|November 24, 2018
Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomesAnnette E Hay, Joseph L Pater, Elyse Corn, et al.
Journal of the National Cancer Institute|March 24, 2021
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group ExperienceJoseph C Del Paggio, Adam M Fundytus, Wilma M Hopman, et al.
Journal of Pain and Symptom Management|April 3, 2007
A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patientsDeborah J Dudgeon, Eduardo Bruera, Bruno Gagnon, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 19, 2020
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the LiteratureBethany E Monteith, Christopher P Venner, Donna E Reece, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)Andrea Bezjak, Peter Dixon, Michael Brundage, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry DataAnnette E Hay, Nicole Mittmann, Michael Crump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2005
Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal womenTimothy J Whelan, Paul E Goss, James N Ingle, et al.
Pageof 3